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Abstract 
The catalytic oligomerisation of ethylene with chromium-based complexes containing 
bis(benzimidazolemethyl)amine (BIMA) ligands results in alternating distributions of linear 
α-olefins (LAOs).  Extremely high activities are obtained (>100,000 gmmol–1h–1bar–1) with 
N-alkyl substituted BIMA ligands, whereas bulky groups on the central nitrogen or 
alternative central donors result in much lower activities.  Variations in the ligand backbone, 
as well as methylation of the benzimidazole units lead to reduction in activity.  The 
alternating LAO distributions have been mathematically analysed using second order 
recurrence relations.  The shape of the distributions is affected by ethylene pressure (1–4 bar) 
and by the co-catalyst to some degree.  Based upon the results and analysis presented herein, 
we propose that the alternating behaviour originates from the ability of these chromium 
BIMA catalysts to undergo single as well as double ethylene insertion reactions.  A minor 
second distribution (<5 wt%) of 2-ethyl-1-alkenes is obtained under certain conditions, 
resulting from incorporation of 1-butene.  DFT studies (M06L) and experimental 
observations regarding the reaction between AlMe3 and the N-methyl BIMA ligand 2 have 
shown that deprotonation of the benzimidazole N-H units can occur, which suggests a change 
in coordination of the BIMA ligand under oligomerisation conditions. 
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Introduction 
Linear α-olefins (LAOs) are important chemical intermediates for the production of 
detergents, lubricants and as co-monomers in linear low density polyethylene (LLDPE).1-4  
Several commercial processes produce LAOs with different distributions of chain lengths.  
The Alfen process involves stepwise insertions of ethylene into the Al–C bonds of aluminium 
alkyls, resulting in a range of LAOs that follow a Poisson distribution.  The Shell Higher 
Olefin Process (SHOP) oligomerises ethylene with a nickel-based catalyst (see Figure 1),5 
where chain propagation competes with chain termination according to the Cossee 
mechanism,6 resulting in LAOs with a Schulz-Flory distribution.7,8  Several chromium 
complexes have been reported that oligomerise ethylene with high selectivity to 1-hexene or 
1-octene, for example those based on PNP ligands,9-12 and more recently with PNC=N and 
PC=N ligand systems.13,14  The trimerisation of ethylene to 1-hexene with a 
pyrrole/chromium-based catalyst is operated by the Phillips Petroleum Company,15 and Sasol 
has recently commercialised a tri/tetramerisation technology based on PNP/chromium 
catalysts for the production of 1-hexene and 1-octene.16  Some examples of commercial 
oligomerisation catalysts are collected in Figure 1.  Deuterium labelling studies have shown 
that many chromium catalysts operate via a metallacyclic mechanism rather than a Cossee 
chain growth mechanism.17-19 
 
 
Figure 1.  Examples of commercial ethylene oligomerisation catalysts (X = appropriate 
anion). 
 
In 2006, Tomov et al. reported a chromium bis(benzimidazole)methylamine (BIMA) 
complex which, in combination with MAO as the co-catalyst, generates a highly active 
ethylene oligomerisation catalyst with activities of 100,000 gmmol−1h−1bar−1.20  An unusual 
alternating distribution of LAOs was obtained which was very different from Schulz-Flory or 
Poisson distributions.  The α-olefins formed from an odd number of ethylene units (n = 1, 3, 
5 etc.) are significantly less abundant than the even-numbered oligomers such as 1-butene (n 
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= 2), 1-octene (n = 4) and 1-dodecene (n = 6).  An example of a chromatogram for a 
distribution obtained with a BIMA chromium catalyst is shown in Figure 2.  Alternating 
distributions are still very rare and have only been observed with chromium-based catalysts, 
but are not exclusive to BIMA-type ligands.21 
 
  
  
Figure 2. GC-FID analysis of an alternating olefin distribution obtained with chromium 
BIMA catalyst [Cr(2)Cl3]/MAO (* = standard 2,2,4,4,6,8,8-heptamethyl nonane). 
 
Here, we report a comprehensive study on these extremely active and remarkable 
chromium BIMA oligomerisation catalysts.  The effects of different ligands, the coordination 
geometry around chromium, reaction parameters such as pressure and the nature of the co-
catalyst on catalytic activity and product distribution have been investigated.  Alternating 
distributions can be mathematically described by second order recurrence relations, which are 
related to first order recurrence relations, for example the Schulz-Flory distribution.22  
Detailed analysis of the product distribution, including all side products, has led to a 
mechanistic proposal that involves a metallacyclic mechanism whereby both single and 
double ethylene insertion in the metallacycle are key steps in the oligomerisation process.  
 
Results and Discussion 
 
Ligand and Complex Synthesis 
A series of nitrogen-based ligands 1-21 has been prepared, based on the original 
bis(benzimidazolemethyl)amine (BIMA) ligand 2 (see Figure 3).  The synthesis and 
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characterising data of ligands 2, 6, 8, 9, 10, 11, 13 and 16,23 as well as 4, 5 and 12,24,25 have 
been previously reported.  The BIMA ligands 1, 14 and 15,26 as well as 17,27 2028 and 2129 
have been prepared by published methods and our 1H NMR values agree with those reported 
previously.  The extended ligands 18 and 19 were prepared according to a published 
procedure by condensation of phenylene diamine with 3,3’-iminodipropionitrile and our 
NMR data agreed with the data provided.30,31 The new ligands 3 and 7 were prepared by 
conventional condensation of phenylene diamine with N-alkyl iminodiacetic acid diethylester 
(see Experimental Section).   
 
Figure 3.  Overview of ligands 1 – 21. 
The syntheses and characterisation of complexes [Cr(2)Cl3]20 and [Cr(17)Cl3]27,32 have 
been described previously. All other chromium trichloride complexes [Cr(L)Cl3] were 
prepared by combining equimolar amounts of [CrCl3(thf)3] and the relevant ligand in 
tetrahydrofuran.  The resulting paramagnetic Cr(III) complexes were insoluble in most 
common organic solvents and were analysed by mass spectrometry, infra-red spectroscopy, 
magnetic susceptibility measurements and elemental analyses.  X-ray analysis was carried out 
on crystals obtained from dimethylformamide (DMF) solutions for complexes [Cr(3)Cl3], 
[Cr(15)Cl3] and [Cr(21)Cl3].  The structure of complex [Cr(3)Cl3] is shown in Figures S15-
16, whereas the latter two complexes are shown in Figure 4.  In the case of ligand 5, the ionic 
complex [Cr(5)Cl2(dmf)]Cl crystallised from a DMF solution, rather than the neutral complex 
[Cr(5)Cl3] (see Figure S21).   
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Figure 4.  Molecular structures of the complexes fac-[Cr(15)Cl3] and mer-[Cr(21)Cl3]. 
The poor solubility of the neutral complexes can be improved by their conversion into 
ionic complexes, for example with AgSbF6. This enabled isolation and crystallisation of the 
cationic complexes [Cr(1)Cl2(OH2)](SbF6) and [Cr(9)Cl2(thf)](SbF6), the molecular 
structures of which can be found in Figures S20 and 5, respectively.   An alternative 
chromium source [Cr(CO)6] was also investigated, which gave access to complex 
[Cr(2)(CO)3] which was characterised by NMR and X-ray diffraction (see Figure 5).  
Chromium(0) carbonyl complexes with phosphine ligands have been oxidised with silver 
salts to chromium(I) complexes and used as catalyst precursors in ethylene 
oligomerisation.33,34 
 
Figure 5.  Molecular structures of the cationic complex fac-[Cr(9)Cl2(thf)](SbF6) (SbF6– 
anion has been omitted for clarity) and fac-[Cr(2)(CO)3]. 
6 
 
 
Bis(benzimidazole) ligands generally adopt a facial (fac) coordination mode around the 
chromium centre, as seen previously in [Cr(2)Cl3]35 and here in complexes [Cr(3)Cl3], 
[Cr(15)Cl3] and [Cr(2)(CO)3], and in the cationic complexes [Cr(5)Cl2(dmf)]Cl, 
[Cr(9)Cl2(thf)](SbF6).  The chloro ligand trans to one of the benzimidazole units is 
substituted in these fac complexes.  Meridional (mer) coordination is less common and is 
seen with smaller ligands, for example in the bis(benzimidazole)amine complex 
[Cr(1)Cl2(OH2)](SbF6) and the bis(pyrazole)butylamine complex [Cr(21)Cl3], suggesting that 
the size of the ligands may affect the coordination mode.  The chloro ligand trans to the 
central amine donor is substituted in the cationic mer complex.  The difference between the 
fac/mer coordination modes appears to be rather subtle, as both can be obtained with 
seemingly similar ligands.  For example, the mer geometry is observed for the bis(pyrazole) 
amine ligand 21 in [Cr(21)Cl3], whereas a fac mode has been reported for the very similar N-
methyl ligand.36  Furthermore, the same ligand can show different coordination modes in 
different complexes, for example ligand 2 coordinates in a fac mode in [Cr(2)Cl3], but a mer 
coordination is observed in [Cr(2)Cl(acac)](SbF6) when a bidentate acac ligand is 
employed.20,35 
 
Ethylene Oligomerisation Results 
The chromium(III) complexes [Cr(L)Cl3], where L = 1 – 21 have been applied as catalysts 
for the oligomerisation of ethylene (Table 1).  The liquid fractions have been analysed by 
FID-GC and the solid fractions by GPC in selected cases.  For those catalysts that give an 
alternating olefin distribution, up to approximately 20 wt% of the total product collected is in 
the liquid phase, consisting of essentially pure C4-C38 LAOs.  The gas phase contains 
predominantly ethylene and butene, which were not quantified.  Solid polyethylene (80-100 
wt%) constitutes the remainder of the product spectrum and the fraction with Mn values 
between 1000-2000 is the tail end of the overall LAO distribution.  Based on several identical 
runs, the error in terms of activity and product selectivity values was estimated to be 
approximately 10% (see Table S1 and Figure S7). 
 
Table 1. Ethylene oligomerisation results with [Cr(L)Cl3]/MAO (L = 1 – 21). 
 Catalyst (µmol) Activity Liquid Schulz-Flory Solid PE 
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Run wt% (LAO) α Mn Mw PDI 
1 [Cr(1)Cl3] (0.03) 15,000 18 (99)     
2 [Cr(2)Cl3] (0.03) 102,000 21 (99)  1,920 3,530 1.8 
3 [Cr(3)Cl3] (0.03) 96,000 11 (97)  1,240 4,790 3.9 
4 [Cr(4)Cl3] (0.03) 97,000 6 (92)  1,250 5,620 4.5 
5 [Cr(5)Cl3] (0.03) 39,000 12 (97)  2,550 9,400 3.7 
6 [Cr(6)Cl3] (0.03) 20,000 3 (98)  7,710 127,710 16.6 
7 [Cr(7)Cl3] (0.03) 27,000 4 (99)  6,310 131,130 20.8 
8 [Cr(8)Cl3] (0.03) 11,000 0  8,890 158,700 17.9 
9 [Cr(9)Cl3] (0.03) 11,000 5 (99)  3,930 92,830 23.7 
10 [Cr(10)Cl3] (0.03) 5,000 17 (98)  2,470 24,150 9.8 
11 [Cr(13)Cl3] (0.03) 320 nd     
12 [Cr(14)Cl3] (0.3) 2,200 11 0.95    
13 [Cr(15)Cl3] (0.4) 75 46 0.79    
14 [Cr(16)Cl3] (2) 770 92 0.55    
15 [Cr(17)Cl3] (1) 2,500 79 (99) 0.87 710b)   
16 [Cr(18)Cl3] (10) 44 20 (99)     
17 [Cr(19)Cl3] (10) 21 9 (99) 0.62    
18 [Cr(20)Cl3] (5)a) 16 0     
19 [Cr(2)Cl2(thf)](SbF6) (0.03) 16,000 21 (98)  1,200b)   
20 [Cr(9)Cl2(thf)](SbF6) (0.03) 16,000 9 (99)  2,800b)   
21 [CrCl3(thf)3] (25)c) 88 96 (99) 0.54    
Conditions: 4 bar ethylene pressure, 50 ˚C, MAO (120 equiv.), toluene 200 mL, 1 hour. Activity in gmmol–1h–
1bar–1.  a) 1 barg ethylene pressure. b) determined by 1H NMR. c) 4 barg ethylene pressure, 50 ˚C, MMAO-12 
(500 equiv.), toluene 100 mL, 1 hour. 
 
Extremely high activities in excess of 100,000 gmmol–1h–1bar–1 can be obtained with 
chromium BIMA complexes, for example ligands 2 – 4 with n-alkyl substituents (Me, nBu or 
nHex, runs 2-4).  Catalytic activities are very sensitive to the nature of the substituent at the 
central amine.  Complex [Cr(1)Cl3] with a hydrogen substituent at the central nitrogen is 
significantly less active at 15,000 gmmol-1h-1bar-1.  More bulky substituents (iPr, tBu, Cy, Bz 
and Ph) at the central nitrogen donor in complexes [Cr(6)Cl3]-[Cr(10)Cl3] lead to a reduced 
catalytic activity, less toluene-soluble olefins and progressively higher molecular weight 
polyethylene.  The 2,6-dimethylphenyl complex [Cr(11)Cl3] was inactive under these 
conditions and it is likely that the central amine is not coordinated in this case, as seen for an 
analogous cobalt(II) complex.23  The cationic complex [Cr(2)Cl2(thf)](SbF6) shows a lower 
activity compared with [Cr(2)Cl3] (runs 2 and 19),20 whereas similar results are obtained for 
[Cr(9)Cl2(thf)](SbF6) versus [Cr(9)Cl3] (runs 9 and 20).  The catalyst precursor [CrCl3(thf)3] 
without any additional ligand gives a Schulz-Flory distribution with very low activity (run 
21).  It appears that small alkyl substituents such as methyl or higher linear alkyls at the 
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central nitrogen provide an optimal donor strength, both sterically and electronically, for high 
catalytic activity.   
Substitution at the benzimidazole nitrogens reduces the activity dramatically. For example, 
complex [Cr(13)Cl3] with methylated benzimidazoles shows an activity of 320 gmmol–1h–
1bar–1.  The related complex [Cr(12)Cl3] with a central NH amine donor was inactive under 
the conditions used.  Changing the central amine to other donors such as oxygen or sulfur in 
complexes [Cr(14)Cl3] and [Cr(15)Cl3] or a non-coordinating CH(CH3) unit in complex 
[Cr(16)Cl3] reduces the activity significantly compared with [Cr(2)Cl3].  Coordination of the 
central sulfur donor in [Cr(15)Cl3] is confirmed by X-ray analysis (see Figure 4), but this 
coordination is weak judging from the long Cr–S distance of 2.415(3) Å.  Similarly, 
coordination of the central oxygen donor in complex [Cr(14)Cl3] is unlikely, considering the 
very long metal oxygen distances seen in other complexes with this ligand.37,38  A strongly 
coordinating central donor appears to be essential for high catalytic activity and only sp3-
hybridised amine donors result in an alternating olefin distribution.  A sp2-hybridised 
nitrogen donor, such as pyridine in complex [Cr(17)Cl3], shows a significantly lower activity 
and, more importantly, gives a Schulz-Flory distribution of LAOs with α = 0.87.39  A Schulz-
Flory distribution is also observed for the distributions obtained with complexes [Cr(14)Cl3] - 
[Cr(16)Cl3], where α is 0.95, 0.79, and 0.55 respectively. 
Extending the bridge between the central donor and the benzimidazole units with an extra 
methylene unit, as in [Cr(18)Cl3], results in significantly lower activity compared with 
[Cr(1)Cl3].  The activity is further reduced for [Cr(19)Cl3] with N-methylated benzimidazole 
units, as seen for [Cr(12)Cl3] versus [Cr(1)Cl3].  Removal of the central donor in [Cr(20)Cl3] 
or changing the benzimidazoles to pyrazole units in [Cr(21)Cl3] results in very low 
polymerisation activity.  Similar activities have been reported for related chromium catalysts 
with bis(pyrazole)amine ligands,40,41 whereas selective ethylene trimerisation was reported 
with facially coordinating tridentate bis(pyrazolyl) ligands.42 
 
Distribution analysis 
Chain growth in ethylene oligomerisation can occur via different mechanisms, depending 
on the catalyst employed.  For chromium complexes containing BIMA ligands, a 
metallacyclic mechanism is implicated based on deuterium labelling studies.20  If chain 
growth proceeds via the coordination and insertion of single ethylene monomers, a Schulz-
Flory distribution is obtained, as seen for example for the chromium complexes with ligands 
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14-17 and 19 (see Table 1).  Schulz-Flory distributions can be mathematically described as a 
first order linear homogeneous recurrence relation with constant coefficients and the solution 
to this relation results in the typical Schulz-Flory equation: mol(n) = (1–α)αn–1R, where n is 
the number of ethylene units in the oligomer and R is the total molar amount of oligomers 
produced within the reaction time.  The term α is the probability of chain propagation, which 
is defined by the rate of propagation divided by the sum of the rate of propagation and 
termination.  The term 1–α represents therefore the probability of chain termination.  The 
mol% fraction for each oligomer equals mol%(n) = mol(n)/R = (1–α)αn–1.43 
Alternating LAO distributions, as obtained here with chromium complexes containing 
ligands 1-10, 13 and 18, can be mathematically described as a second order linear 
homogeneous recurrence relation with constant coefficients.43  Each oligomer fraction is 
related to the previous fraction and the one before by the parameters α and β respectively, 
which are the probabilities of chain growth via single ethylene insertion (α) and double 
ethylene insertion (β) (see Scheme 1).  The term 1–α–β represents the probability of 
termination. 
 
Scheme 1: Ethylene oligomerisation resulting in alternating distributions 
 
The general solution to this recurrence relation takes the form mol(n) = c1r1n + c2r2n, 
whereby c1,2 and r1,2 are related to α and β.43 Experimental data obtained for an alternating 
distribution can be fitted to this equation to determine c1,2 and r1,2, and thereby α and β and 
1–α–β.  Data fitting analysis is performed using the C10-C34 LAO fraction (n = 5-17) and the 
goodness of fit is expressed by the R2 values in the last column in Table 2.  The C4-C8 
oligomers are omitted because 1-butene (C4) is too volatile for quantitative analysis and, as 
will be explained below, the experimental values for 1-hexene (C6) and 1-octene (C8) can 
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sometimes deviate from the values calculated from the distribution analysis based on C10-C34.  
The analysis for a selection of distributions is collected in Table 2 and two graphical 
examples are shown in Figure 6.  Other distributions can be found in the Supporting 
Information. For example, data fitting analysis of the oligomerisation results from C10-C34 for 
complex [Cr(4)Cl3] (run 4, Table 1) provides the equation mol%(n) = 15.75(0.91)n + 15.62(–
0.80)n for this particular distribution.  The probabilities for single and double coordination are 
determined as α = 0.11 and β = 0.72 and the probability for termination is 1–α–β = 0.17.   
 
Table 2.  Analysis of alternating distributions.a 
Catalyst Σmmol(n)b mol%(n) = c1r1n + c2r2n α β 1-α-β β/α c2/c1 R
2c 
[Cr(1)Cl3]  0.82 18.77(0.89)n + 3.64(–0.82)n 0.07 0.72 0.21 10.2 0.19 0.998 
[Cr(2)Cl3] 15.64 25.16(0.90)n + 23.06(–0.79)n 0.11 0.72 0.17 6.41 0.92 0.997 
[Cr(4)Cl3] 18.94 15.75(0.91)n + 15.62(–0.80)n 0.11 0.72 0.17 6.55 0.99 0.997 
[Cr(18)Cl3] 1.02 13.28(0.92)n + 5.58(–0.87)n 0.05 0.79 0.15 15.3 0.42 0.984 
a) Conditions: see Table 1. b) Experimental total moles of LAOs from n = 3-17. c) R2 signifies the goodness of 
fit of the calculated values compared with the experimental data.   
 
  
Figure 6.  Experimental LAO distributions in mol%(n) versus n obtained with [Cr(1)Cl3] 
(left) and [Cr(4)Cl3] (right) together with calculated best-fit distributions (n = number of 
ethylene units in oligomer). 
 
The relation mol%(n) = c1r1n + c2r2n can be explained as an exponential decay function c1r1n 
with a positive decay parameter r1, combined with an alternating function c2r2n with a 
negative parameter r2.  The relative importance of the various parameters c1,2 and r1,2 can be 
illustrated using the two examples shown in Figure 6.  The r1 and r2 factors determine the 
steepness of the exponential decay functions.  The degree of alternation is indicated by the 
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weighting factors c1 and c2 and the ratio c2/c1 gives an indication of the extent of alternation.  
For example, for [Cr(1)Cl3] the relatively small degree of alternation is indicated by the 
smaller value of c2/c1 = 0.19, whereas alternation is much more pronounced for [Cr(4)Cl3] 
where c2/c1 = 0.99. 
In many cases, differences are observed between the experimental amounts obtained for 1-
hexene (C6) and 1-octene (C8) and those extrapolated from the C10-C34 distribution.  These 
minor deviations are attributed to differences in the probabilities for metallacycle growth (α 
and β) and termination (1–α–β) for smaller metallacycles early on in the oligomerisation 
process.  These differences become negligible for larger metallacycles beyond 
metallacyclononane (C8), and the propagation and termination probabilities converge to 
constant values.  The small deviations observed here for C6 and C8 with chromium BIMA 
catalysts are probably related to other chromium-based catalysts where differences at the 
early stages of metallacycle growth lead to oligomerisations where 1-hexene or 1-octene 
become the major products of the distribution.43 This is for example observed with 
chromium-based selective oligomerisation catalysts. 
 
Effect of pressure 
Ethylene oligomerisation with catalyst [Cr(17)Cl3], which contains a meridional ligand 17 
with a central pyridine donor, results in a Schulz-Flory distribution of LAOs.39  The total 
oligomer yield obtained at different gauge pressures from 1–4 bar follows a first order 
dependence on ethylene concentration (see Figure S2).  The order in ethylene concentration 
for individual LAOs is conveniently determined from the slope in a ln(rate) versus 
ln[ethylene] plot,44 whereby ethylene pressure is a reliable proxy for concentration in 
solution.44,45  The rate can be approximated by the amount of LAO produced within a given 
time.  A first order dependence on ethylene pressure is observed for individual LAOs in this 
case and the difference for example between the orders for 1-octene and 1-hexene formation 
is very close to zero (see Figure S5).  The LAO distribution is characterised by α = 0.87, 
which is independent of ethylene pressure within the pressure range from 1–4 bar.  Because α 
is equal to the rate of propagation divided by the rate of propagation plus the rate of 
termination, this suggests that both the rate of propagation and the rate of termination are 
affected in a similar manner by ethylene concentration and that therefore chain transfer to 
monomer must be the main termination pathway (rather than β-H elimination).   
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The effect of pressure on alternating distributions has been investigated for catalysts 
[Cr(1)Cl3] and [Cr(4)Cl3] at ethylene gauge pressures between 1–4 bar.  The total yield of 
oligomers increases with a first order dependence on ethylene pressure in both cases (see 
Figures S3-S4).  Figure 7 shows that the degree of alternation becomes more pronounced at 
higher pressure such that individual oligomers appear to have different orders in ethylene.  
Indeed, the difference between the orders for 1-octene and 1-hexene formation is distinctly 
non-zero (see Figure S6).  The higher order for the formation of 1-octene with respect to 1-
hexene suggests a different mechanism involving both single and double insertions of 
ethylene in the case of 1-octene formation, whereas 1-hexene formation proceeds via single 
ethylene insertions only. 
 
Figure 7.  Pressure dependence of the LAO distribution with [Cr(4)Cl3]. Conditions: see 
Table 3. 
 
Table 3.  Pressure dependence of the LAO distribution with [Cr(4)Cl3]/MAO. 
Pa) Olig./mmolsb) mol%(n) α β 1-α-β β/α c2/c1 R2 c 
1 barg 1.24 13.23(0.92)n + 9.93(–0.79)n 0.13 0.73 0.14 5.77 0.75 0.979 
2 barg 1.88 12.99(0.92)n + 11.29(–0.81)n 0.12 0.74 0.15 6.22 0.87 0.993 
3 barg 2.35 13.79(0.92)n + 14.18(–0.81)n 0.11 0.75 0.16 6.93 1.03 0.996 
4 barg 4.07 14.64(0.91)n + 14.70(–0.81)n 0.10 0.74 0.16 7.06 1.00 0.996 
Conditions: [Cr(4)Cl3] 30 nmol, 50 oC, 1 hour, 200 mL toluene, MAO (5 mmol). a) 1 barg (bar gauge) = 2 bara 
(bar absolute) = 1 bar nitrogen + 1 bar ethylene. b) Oligomers from n = 3-19 c) R2 signifies the goodness of fit 
of the calculated values compared with the experimental data.   
 
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
0 10 20 30 40
Amount of 
Oligomer 
(mmol) 
Carbon Number 
1 bar
2 bar
3 bar
4 bar
13 
 
From Table 3 it appears that the ratio between the propagation probabilities for double 
versus single ethylene insertion (β/α) is pressure dependent.  The increase in β/α shown in 
Figure 8 suggests that double insertion becomes more likely than single insertion at higher 
pressure.  While the trend appears to be linear within this pressure regime, it is unclear at this 
stage whether this trend continues at higher or lower pressures. 
 
 
Figure 8. Dependence of β/αon ethylene gauge pressure. Trendline: linear (R2 = 0.944).  
Conditions: catalyst [Cr(4)Cl3] (30 nmol), 50 oC, 1 hour, 200 mL toluene, MAO (5 mmol).   
 
 
Effect of different co-catalysts 
Different co-catalysts have been evaluated in combination with BIMA catalyst [Cr(2)Cl3].  
All co-catalysts listed in Table 4 provide active catalyst systems and the activities can vary 
considerably.  MAO provides the best activity, but yields the lowest amount of oligomers in 
the liquid fraction.  The combination of an alkylating reagent (AlMe3) with several 
abstracting reagents (B(C6F5)3, [Ph3C][B(C6F5)4] or [PhNMe2H][B(C6F5)4]) gives somewhat 
lower activities, but a larger oligomer fraction.  Somewhat surprisingly, AlMe3 without an 
abstractor also shows a reasonable activity with a comparable oligomer distribution.  
Experimental and calculated distributions can be found in Figures S8-12. While the 
differences between the distributions appear to be small, given the 10% error margin (see 
Table S1), we do believe they are significant.  It appears that the nature of the co-catalyst can 
affect the oligomer distribution to some degree and that a trialkyl aluminium in general is an 
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important aspect of the co-catalyst, something that will be discussed in more detail in the last 
section. 
 
Table 4.  Effect of different co-catalysts on the oligomer distribution with [Cr(2)Cl3]. 
Co-catalyst Act.a) 
 
Liq.  
wt% 
mol%(n) α β 1-α-β β/α R2 
MAO 18,500 8 17.60(0.89)n + 19.03(–0.77)n 0.12 0.69 0.20 5.92 0.994 
B(C6F5)3/AlMe3 8,000 32 17.81(0.89)n + 10.61(–0.76)n 0.13 0.68 0.20 5.39 0.998 
[Ph3C][BArF]/AlMe3 12,000 35 18.02(0.89)n + 16.30(–0.74)n 0.15 0.66 0.19 4.49 0.999 
[PhNMe2H][BArF]/AlMe3 13,200 46 21.10(0.87)n + 15.39(–0.79)n 0.09 0.69 0.22 8.00 0.998 
AlMe3 4,800 32 18.07(0.89)n + 17.11(–0.72)n 0.16 0.64 0.20 3.91 0.996 
Conditions: catalyst [Cr(2)Cl3] 0.5 µmol, 4 barg, 1 hour, 50 ˚C, 200 mL toluene. a) Activity in gmmol–1h–1bar–1. 
Co-catalysts: MAO: 3 mmol (6000 equiv.); B(C6F5)3, [Ph3C][BArF] and [PhNMe2H][BArF]: 0.5 mmol (1 equiv.) 
and AlMe3: 0.5 mmol (1000 equiv.) [BArF]– = [B(C6F5)4]–.  
 
 
Side products 
The selectivity for the formation of LAOs obtained with chromium BIMA catalysts is 
generally very high, typically in excess of 95% (see Table 1).  In addition to the main LAO 
distribution, a second minor distribution can sometimes be observed, depending on the 
reaction conditions.  This minor distribution follows the opposite alternating pattern 
compared to the main distribution, i.e. oligomers derived from an odd number of ethylene 
units are more abundant than those from an even number, as can be seen in Figure 2.  
Because 1-butene is the major product in these oligomerisation reactions, the second minor 
distribution is generated from incorporation of 1-butene into the oligomerisation reaction, as 
shown in Equations 2 and 3.  This was confirmed by oligomerisation experiments of ethylene 
with additional 1-butene, using catalyst [Cr(2)Cl3] (Table 5).  In the absence of 1-butene, the 
wt% ratio between the major and minor fraction is approximately 17:1, which changes to 5:1 
upon addition of an excess of 1-butene.  The identity of the minor products was confirmed as 
a distribution of 2-ethyl-1-alkenes, based on NMR and GC analysis (see Figure S13) and 
comparison with an authentic sample of the C6 product 2-ethyl-1-butene (m = 1 in Eq. 3).  
Co-oligomerisation of ethylene with higher 1-alkenes is known to occur with chromium-type 
oligomerisation catalysts that operate via a metallacyclic mechanism.19,46-49   
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The activity of the catalyst system [Cr(2)Cl3]/MAO decreases significantly from 54,900 to 
8,400 gmmol–1h–1bar–1 upon addition of a large excess of 1-butene.  Additional 1-butene is 
likely to slow down the rate of oligomerisation due to coordination to the metal centre, which 
will require substitution by ethylene before metallacycle growth can proceed.  No oligomers 
due to the oligomerisation of 1-butene alone are observed. 
The distribution of the major 1-alkene fraction differs from the 2-ethyl-1-alkene fraction in 
that, aside from the opposite alternating behaviour, the probability for termination (1–α–β) is 
significantly higher for the latter, cf. 0.36 versus 0.22 (0.28 versus 0.22 with additional 1-
butene).  As a result, the amount of 2-ethyl-1-alkene isomer produced will decrease more 
rapidly than the amount of 1-alkene and therefore the selectivity to 1-alkenes will increase 
across the product distribution.  Termination via β-H transfer is expected to be faster for 
weaker tertiary C–H bonds in the 2-ethyl metallacyclic complex in Eq. 3.  The addition of 1-
butene affects the distribution in the 1-alkene and 2-ethyl-1-alkene fractions, as seen from the 
β/α ratios, which decrease from 5.89 to 3.99 and from 9.30 to 4.59, respectively.  Different 
distributions for both fractions imply that 1-butene incorporation into the metallacycle affects 
the distribution and 1-butene must therefore be incorporated at the beginning of metallacycle 
formation and not at the end.  A stronger binding of 1-butene, but lower reactivity compared 
to ethylene provides an explanation for the observed behaviour.  These observations made 
here for 1-butene may also apply to other 1-alkenes and implies a general inhibition of the 
oligomerisation reaction by the higher alkene products. 
 
Table 5.  Effect of addition of 1-butene on the 1-alkene and 2-ethyl-1-alkene distributions 
with [Cr(2)Cl3]/MAO. 
 Act.c) wt%d) mol%(n)e) α β 1-α-β β/α R2 
1-alkenesa) 55,900 17 21.04(0.88)n + 20.58(–0.76)n 0.11 0.67 0.22 5.89 0.996 
2-ethyl-1-alkenesa)  1 36.16(0.79)n + 26.39(–0.73)n 0.06 0.58 0.36 9.30 0.999 
1-alkenesb) 8,400 29 22.45(0.87)n + 24.85(–0.71)n 0.16 0.62 0.22 3.99 0.996 
2-ethyl-1-alkenesb)  6 23.97(0.83)n + 27.14(–0.71)n 0.13 0.59 0.28 4.59 0.999 
16 
 
a) Conditions: catalyst [Cr(2)Cl3] (30 nmol), MAO (7 mmol), 4 bar, 1 hour, 50 ˚C, 200 mL toluene. b) 
Conditions: [Cr(2)Cl3] 150 nmol, MAO (7 mmol), 4 bar, 1 hour, 50 ˚C, 200 mL toluene, 1-butene (3.5 g) added. 
c) Activity in gmmol–1h–1bar–1, includes 1-alkenes, 2-ethyl-1-alkenes and polymer. d) weight percentage of 
olefins in the liquid fraction, remainder is solid polyethylene. e) 1-alkenes distribution: n = 1 is ethylene, n = 2 is 
1-butene etc.; 2-ethyl-1-alkenes distribution: n = 1 is 1-butene, n = 2 is 2-ethyl-1-butene etc. 
 
 
Mechanistic considerations 
Single and double coordination mechanism 
Chain growth in chromium-based BIMA catalysts proceeds via a metallacyclic 
mechanism.39    A single coordination mechanism, i.e. coordination and insertion of a single 
ethylene unit at a time, results in a Schulz-Flory distribution, which is observed for example 
with chromium catalysts of ligands 14 – 17 that do not have a central amine donor.  An 
alternating distribution is obtained via a double insertion mechanism, whereby two ethylene 
monomers coordinate to the chromium centre and insert sequentially.43  In this case, the 
termination probability after the first insertion is zero and the metallacycle effectively grows 
by two ethylene units at a time. The single and double insertion mechanisms can operate in 
parallel and the extent of each is determined by the probabilities α and β, which are affected 
by the catalyst, ethylene pressure, temperature, and the coordinating properties of the solvent 
and the anion (co-catalyst).  We have previously established a double insertion route as the 
main mechanism in ethylene tetramerisation with Cr-PNP catalysts.22 
The growth of the metallacycle by single ethylene insertion requires a facial arrangment of 
the metallacyle and the ethylene monomer prior to insertion (Figure 9a).  The insertion of two 
ethylene monomers requires double ethylene coordination. This arrangement can lead to the 
sequential insertion of two ethylene units without termination by β-H transfer after the first 
insertion.  For each insertion step, the metallacycle and the ethylene monomer must be in 
facial orientation, as illustrated in Figure 9b.  
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Figure 9.  Metallacycle growth via (a) single and (b) double ethylene coordination and 
insertion. 
 
Structural studies (vide infra) have shown that BIMA ligands can coordinate in a tridentate 
fac or mer fashion (see Figure 4) and a strong binding of the central donor was found to be 
essential for high catalytic activity.  Coordination of two ethylene units to a chromium BIMA 
metallacyclic complex would generate a seven-coordinate complex, unless one of the donors 
dissociates.  To explore this further, we investigated two related bidentate benzimidazole 
pyridine and benzimidazole amine ligands 22 and 23 (see Eq. 3).   Combination of these 
ligands with [CrCl3(thf)3] is assumed to generate complexes of the type [Cr(L)Cl3(thf)], as 
reported for similar bidentate nitrogen donor ligands.49-51  Very low activities were observed 
for both catalysts (see Table 6).  Similar reduction in catalytic activity was observed by 
McGuinness with tridentate versus bidentate pyridine carbene ligands.49  The chromium 
complex with benzimidazole pyridine 22 resulted in a Schulz-Flory distribution of LAOs, 
similar to the oligomerisation with the bis(benzimidazole) pyridine ligand 17 (see Table 1, 
run 15).  The distribution obtained with ligand 23 showed alternating behaviour (Table 6).  
Tridentate BIMA ligands clearly give a much better performance than the bidentate ligands 
22 and 23.  Notwithstanding, partial dissociation of one donor during metallacycle growth to 
provide the necessary coordination sites for two ethylene monomers, cannot be dismissed 
from these results. 
 
Table 6.  Alkene distributions with [CrCl3(thf)3]/22, [CrCl3(thf)3]/23 and 
[CrCl3(thf)3]/[(AlMe2)2(2')]3.a) 
 Act.b) wt%c) mol%(n)d) α β 1-α-β β/α R2 
[Cr]/22 10 34 SF 0.62    0.999 
[Cr]/23 13 17 12.89(0.79)n + 14.07(–0.63)n 0.16 0.50 0.34 3.12 0.964 
[Cr]/[(AlMe2)2(2')]3e) 2,066 20 27.56(0.89)n + 23.08(–0.80)n 0.09 0.71 0.21 8.32 0.996 
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a) Conditions: catalyst [Cr] = [CrCl3(thf)3]: 25 µmol, ligand 1 equiv., MMAO-12 (12.5 mmol), 4 bar, 1 hour, 50 
˚C, 100 mL toluene. b) Activity in gmmol–1h–1bar–1, includes polymer. c) weight percentage of α-olefins in the 
liquid phase.  d) SF = Schulz-Flory distribution. e) [CrCl3(thf)3]/[(AlMe2)2(2')]3: 100 nmol, MMAO-12 (24 
mmol), 4 bar, 1 hour, 50 ˚C, 200 mL toluene. 
 
The nature of the active species 
It is very likely that during the activation of the BIMA pre-catalyst with the co-catalyst, 
which contains AlMe3, the benzimidazole NH functionalities become deprotonated to give 
anionic benzimidazolide ligands.  This proposal is supported by a separate reaction carried 
out between BIMA ligand 2 and AlMe3 according to Equation 5.  The reaction of 2 with two 
equivalents of AlMe3 in toluene resulted in deprotonation of both benzimidazole NH groups, 
followed by trimerisation to give a hexanuclear aluminium complex [(AlMe2)2(2')]3, which 
was characterised by NMR spectroscopy and X-ray diffraction (see Figure S22).  Related 
cyclic aluminium benzimidazole complexes have been reported previously.52,53 
 
 
These observations suggest that the active species is generated upon reaction of the co-
catalyst (AlMe3) with the chromium trichloride pre-catalyst via deprotonation of the BIMA 
ligand.  The requirement of AlMe3 in the co-catalyst seen earlier is in agreement with this 
proposal.  A polymerisation reaction carried out using a combination of [(AlMe2)2(2')]3, 
[CrCl3(thf)3] and MAO resulted in a moderately active polymerisation system, giving an 
alternating distribution of LAOs (see Table 6).  
The possibility of partial ligand dissociation was also investigated by DFT calculations.   
The relative free energy profile for a series of potential intermediates formed upon reaction of 
BIMA complex [Cr(2)Cl3] (I) with one or two equivalents of AlMe3 is shown in Figure 10.  
Deprotonation by two AlMe3 units (complexes VI-VIII) clearly shows a dramatic lowering 
of the relative energies, which suggests that a modifcation of the coordination environment 
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around chromium upon addition of AlMe3 is very likely.  Further studies on the nature of the 
active species are underway. 
 
Figure 10.  Relative Gibbs free energy profile of potential intermediates formed upon reaction 
of complex I with AlMe3.  All energies are balanced for AlMe3 and, in the case of ligand 
deprotonation, CH4 formation. See Supporting Information for details. 
 
 
In conclusion, chromium-based BIMA complexes are a class of ethylene oligomerisation 
catalysts that, depending on the ligand, can give extremely high catalytic activities and either 
a Schulz-Flory or an alternating distribution of LAOs in the liquid fraction, together with a 
major solid polyethylene fraction.  Schulz-Flory distributions are described by a linear 1st 
order recurrence relation with constant coefficient α, whereas alternating distributions are 
mathematically described by a 2nd order recurrence relation with constant coefficients α and 
β, which represent the probabilities for propagation via the insertion of one or two ethylene 
monomers, respectively.  The β/α ratio increases with ethylene pressure within the range from 
1-4 bar.  A range of different co-catalysts can be used, which affect the catalytic activity and 
the LAO distribution.  The presence of AlMe3 appears to be essential and it is believed to 
react with the facially coordinating BIMA ligand at the chromium centre.  Incorporation of 
the most abundant LAO, 1-butene, can occur during the oligomerisation process, giving rise 
to a minor alternating distribution of 2-ethyl-1-alkenes with opposite alternating behaviour.  
Further studies to understand this intriguing class of oligomerisation catalysts, and our search 
for new catalysts which will generate as yet unseen oligomer distributions, continues. 
 
Experimental Section 
Synthesis of ligands  
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N-bis((1H-benzimidazol-2-yl)methyl)-N-n-butylamine (3) 
Compound 3 was synthesised using o-phenylenediamine (7.56 g, 70.6 mmol) and N,N-
diethylacetate-N-butylamine (8.66 g, 35.3 mmol). o-Phenylenediamine and the iminodiacetic 
acid ethyl ester were stirred at 190 ºC for 4 hours. The water by-product was distilled from 
the reaction mixture which was then allowed to cool to room temperature. The product was 
triturated with water (120 ml), filtered, washed with water (4 x 20 ml), recrystallised from hot 
methanol/water (1:30) and finally dried at 60 ºC under vacuum for two days. Yield 5 g (43 
%).  1H NMR (400 MHz, DMSO-d6, r.t.), δ 0.74 (t, 3H, 3JHH 7.2, CH2CH3), 1.18 (sept, 2H, 
3JHH = 7.1, CH2CH2CH3), 1.45 (quint, 2H, 3JHH 7.4, CH2CH2CH2), 2.5 (overlapping with 
solvent signal, 2H, CH2), 3.97 (s, 4H, NCH2Cq), 7.13-7.17 (m, 4H, JHH 3.1, ArH), 7.53-7.56 
(m, 4H, JHH 3.1, ArH).  13C{1H} NMR (100.6 MHz, DMSO-d6, r.t.) δ 13.8 (CH3), 19.8 
(CH2CH3), 28.5 (CH2CH2), 52.1 (NCH2Cq), 53.4 (NCH2CH2), 114.8 (ArC), 121.5 (ArC), 
138.6 (ArCipso), 152.68 (ArCq).  Anal. Calc. for C20H23N5 (F.W. 333.4) C 72.04, H 6.95, N 
21.00 %. Found C 71.87, H 7.07, N 20.83 %.  CI-MS (m/z); 334 [M+H]+, 362. 
 
N-bis((1H-benzimidazol-2-yl)methyl)-N-tert-butylamine (7) 
Compound 7 was synthesised by an analogous procedure to that described for 3 using o-
phenylenediamine (11.5 g, 106 mmol) and N,N-diethylacetate-N-tert-butylamine (13 g, 53 
mmol). Yield 11.5 g (65 %).  1H NMR (400 MHz, DMSO-d6, r.t.), δ 1.09 (s, CH(CH3)2), 4.00 
(s, (NCH2), 4.10 (s, NCH2), 7.14 (broad m, ArH), 7.53 (broad m, ArH).  13C{1H} NMR 
(100.6 MHz, DMSO-d6, r.t.) δ 26.1 (CH3), 46.1 (NCH2Cq), 54.4 (NC(CH3)3), 115.2 (ArC), 
119.5 (ArC), 134.7 (ArCipso), 152.8 (ArCq).  IR (KBr, cm-1), 3377 (NH, w), 3054 (Ar-H, s), 
1683-1538 (ArC=C, C=N, m), 1456, 1436 (N-H, s), 1271 (CN, s), 749 (CH, s). Anal. Calc for 
C20H23N5 (F.W. 333.4) C 72.04, H 6.95, N 21.00 %. Found C 72.28, H 6.83, N 20.91 %. CI-
MS (m/z), 334 [M+H]+. 
 
Synthesis of chromium complexes 
All Cr(III) complexes are paramagnetic and no NMR spectra could be recorded. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)amine chromium(III) chloride [Cr(1)Cl3] 
 
Equimolar quantities of 1 (1 g, 3.61 mmol) and [CrCl3(THF)3] (1.35 g, 3.61 mmol) were 
stirred in 20 ml of THF for 12 hours. The product was isolated by filtration, washed twice 
with THF (2 x 20 ml), once with diethyl ether (20 ml) and dried under vacuum. Yield 1.49 g, 
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95%.  Anal. Calc. for C16H15Cl3CrN5 (F.W. 435.7): C 44.11, H 3.47, N 16.07 %. Found C 
44.25, H 3.74, N 15.84 %.  IR (KBr, cm–1), 3202 (NH, s), 3120, 3110 (Ar-H, s), 1622-1544 
(ArC=C, C=N, m), 1497, 1477, 1456 (N-H, s), 1278 (CN, s), 743 (CH, s).  UV-VIS (DMF): 
λmax/nm (εmax/dm3mol–1cm–1) = 462 (138), 635 (93), 721 (shoulder).  FAB(+) MS (m/z), 399 
([M–Cl]+), 363 ([M–2Cl]+).  μeff = 3.77 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-methylamine chromium(III) chloride 
[Cr(2)Cl3] 
Complex [Cr(2)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 2 (2 g, 6.87 mmol) and [CrCl3(THF)3] (2.57 g, 6.87 mmol). Yield 2.87 g (93 
%).  Anal. Calc. for C17H17Cl3Cr N5 (F.W. 449.7): C 45.40, H 3.81, N 15.57 %. Found C 
45.35, H 3.76, N 15.66 %.  IR (KBr, cm–1), 3221 (NH, s),1622-1544 (ArC=C, C=N, m), 
1497, 1477,1455 (N-H, s), 1274 (CN, s), 753 (CH, s).  UV-VIS (DMF), λmax/nm (εmax/dm3 
mol–1 cm–1)) = 464 (156), 659 (75), 723 (shoulder).  FAB(+) MS (m/z), 413 [M-Cl]+, 291 [M-
CrCl3]+.  μeff = 3.87 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-butylamine chromium(III) chloride [Cr(3)Cl3] 
 
Complex [Cr(3)Cl3] was synthesised by a procedure analogous to that described for 
[Cr(1)Cl3] using 3 (1 g, 3.03 mmol) and [CrCl3(THF)3] (1.13 g, 3.61 mmol). Yield 1.49 g, 
84%.  Anal. Calc. for C20H23Cl3CrN5 (F.W. 491.8): C 48.85, H 4.71, N 14.24 %. Found C 
48.83, H 4.80, N 14.42 %.  IR (KBr, cm–1), 3440 (NH, m), 3229, 3077 (Ar-H, s), 1623-1549 
(ArC=C, C=N, m), 1499, 1477, 1454, 1433 (N-H, m, s), 1276 (CN, m), 762, 748 (CH, s).  
FAB(+) MS (m/z), 455 [M–Cl]+, 420 [M–2Cl]+.  μeff = 3.89 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-hexylamine chromium(III) chloride 
[Cr(4)Cl3] 
 
Complex [Cr(4)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 4 (1 g, 2.8 mmol) and [CrCl3(THF)3] (1.05 g, 2.8 mmol). Yield 1.35 g, 93%.  
Anal. Calc. for C22H27Cl3CrN5 (F.W. 519.8): C 50.83, H 5.24, N 13.47 %. Found C 51.05, H 
5.30, N 13.38 %.  IR (KBr, cm–1), 3502 (NH, m), 3228, 3073 (Ar-H, s), 1621-1542 (ArC=C, 
C=N, m), 1498, 1477, 1454, 1431 (N-H, s), 1273 (CN, m), 752 (CH, s).  FAB(+) MS (m/z), 
483[M–Cl]+, 448 [M–2Cl]+.  μeff = 3.83 BM. 
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N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(3-phenylpropyl)amine chromium(III) 
chloride [Cr(5)Cl3] 
 
Complex [Cr(5)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 5 (1 g, 2.53 mmol) and [CrCl3(THF)3] (0.95 g, 2.53 mmol). Yield 1.00 g 
(71%).  Attempts to crystallise the complex from a solution in DMF resulted in crystals that 
were found to be the cationic complex [Cr(5)Cl2(dmf)]Cl.  Anal. Calc. for C25H25Cl3CrN5 
(F.W. 553.9): C 54.21, H 4.55, N 12.64 %. Found C 54.32, H 4.79, N 12.50 %.  IR (KBr, cm–
1), 3231 (NH, s), 1622-1543 (ArC=C, C=N, m), 1498, 1477, 1454 (N-H, s), 1274 (CN, m), 
752 (CH, s).  FAB(+) MS (m/z), 517 [M–Cl]+, 482 [M–2Cl]+.  μeff = 3.87 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(iso-propyl)amine chromium(III) chloride 
[Cr(6)Cl3] 
 
Complex [Cr(6)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 6 (0.432 g, 1.35 mmol) and [CrCl3(THF)3] (0.51 g, 1.35 mmol). Yield 1.20 g 
(84%).  Anal. Calc. for C19H21Cl3CrN5 (F.W. 477.8): C 47.77, H 4.43, N 14.66 %. Found C 
47.87, H 4.35, N 14.46 %.  IR (KBr, cm–1), 3440, 3226 (NH, s), 3067 (Ar-H), 1622-1545 
(ArC=C, C=N, m), 1496, 1478, 1455 (N-H, s, m), 1275 (CN, m), 752 (CH, s).  UV-VIS 
(DMF): λmax/nm = 459, 704, 731 (shoulder).  FAB(+) MS (m/z), 441 [M–Cl]+, 406 [M–2Cl]+, 
368 [M–3Cl]+, 320 [M–CrCl3]+.  μeff = 3.46 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(tert-butyl)amine chromium(III) chloride 
[Cr(7)Cl3] 
 
Complex [Cr(7)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 7 (1 g, 3.00 mmol) and [CrCl3(THF)3] (1.01 g, 3.00 mmol). Yield 1.15 g (78 
%).  Anal. Calc. for C20H23Cl3CrN5 (F.W. 491.8): C 48.85, H 4.71, N 14.24 %. Found C 
48.97, H 4.90, N 14.37 %.  IR (KBr, cm–1), 3463 (NH, m), 3192, 3066 (Ar-H, s), 1653-1559 
(ArC=C, C=N, m), 1497, 1477, 1455 (N-H, m, s), 1275 (CN, m), 747 (CH, s).  FAB(+) MS 
(m/z), 455 [M–Cl]+, 420 [M–2Cl]+, 334 [M–CrCl3]+.  μeff = 3.93 BM.  
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(cyclohexyl)amine chromium(III) chloride 
[Cr(8)Cl3] 
 
Complex [Cr(8)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 8 (1 g, 2.79 mmol) and [CrCl3(THF)3] (1.04 g, 2.79 mmol). Yield 1.07 g 
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(74%).  Anal. Calc. for C22H25Cl3CrN5 (F.W. 517.8): C 51.03, H 4.87, N 13.52 %. Found C 
50.93, H 4.72, N 13.64 %.  IR (KBr, cm-1), 3252 (NH, s), 3060 (Ar-H, s), 1622-1538 
(ArC=C, C=N, m), 1496, 1477, 1454 (NH, s, m), 1276 (CN, m), 749 (CH, s).  UV-VIS 
(DMF), λmax/nm (εmax/dm3 mol–1 cm–1) = 459 (160), 704 (65), 731 (shoulder).  FAB(+) MS 
(m/z), 481 [M–Cl]+, 446 [M–2Cl]+, 360 [M–CrCl3]+.  μeff = 3.87 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(phenyl)amine chromium(III) chloride 
[Cr(9)Cl3] 
 
Complex [Cr(9)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using N,N-bis(1H-benzimidazol-2-ylmethyl)-N-phenylamine 9 (0.20 g, 0.56 
mmol) and [CrCl3(THF)3] (0.21 g, 0.56 mmol). Yield 0.23 g (87%).  Anal. Calc. for 
C22H19Cl3CrN5 (F.W. 511.8): C 51.63, H 3.74, N 13.68 %. Found C 51.49, H 3.95, N 13.58 
%.  IR (KBr, cm–1), 3503 (NH, s), 3224, 3065, 1622-1545 (ArC=C, C=N, m), 1497, 1478, 
1454 (NH, s), 1275 (CN, s), 748 (CH, s).  UV-VIS (DMF), λmax/nm = 484, 678, 
705(shoulder).  FAB(+) MS (m/z): 475 [M–Cl]+, 440 [M–2Cl]+, 354 [M–CrCl3]+.  μeff = 3.95 
BM.  
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(benzyl)amine chromium(III) chloride 
[Cr(10)Cl3] 
 
Complex [Cr(10)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using 10 (0.63 g, 1.73 mmol) and [CrCl3(THF)3] (0.65 g, 1.73 mmol). Yield 0.79 g 
(88%).  Anal. Calc. for C23H21Cl3CrN5 (F.W. 525.8): C 52.54, H 4.03, N 13.32 %. Found C 
52.43, H 4.03, N 13.23 %.  IR (KBr, cm–1), 3255 (NH, s), 1617-1550 (ArC=C, C=N, m), 
1496, 1477, 1454 (NH, s, m), 1276 (CN, s), 749 (CH, s).  UV-VIS (DMF, 298 K, λmax/nm 
(εmax/dm3mol–1cm–1)) = 462 (162), 665 (75), 726 (shoulder).  FAB(+) MS: (m/z), 489 [M–
Cl]+, 454 [M–2Cl]+.  µµeff = 4.00 BM. 
 
N,N-bis((1H-benzimidazol-2-yl)methyl)-N-(2,6-dimethylphenyl)amine chromium(III) 
chloride [Cr(11)Cl3] 
 
Complex [Cr(11)Cl3] was synthesised by an analogous procedure to that described for 
[Cr(1)Cl3] using N,N-bis(1H-benzimidazol-2-ylmethyl)-N-(2,6-dimethylphenyl)amine 11 
(0.20 g, 0.53 mmol) and [CrCl3(THF)3] (0.19 g, 0.53 mmol). Yield 0.23 g (81%).  Anal. Calc. 
for C24H23Cl3CrN5 (F.W. 555.9): C 53.40, H 4.29, N 12.97 %. Found C 53.51, H 4.39, N 
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12.82 %.  IR (KBr, cm–1), 3252 (NH, m), 3189 (Ar-H), 1622, 1591, 1520 (ArC=C, C=N, m), 
1466, 1451 (NH, s), 1273 (CN, s), 742 (CH, s).  UV-VIS (DMF), λmax/nm (εmax/dm3 mol–1 
cm–1) = 482 (70), 678(58), 705 (shoulder).  FAB(+) MS (m/z), 503 [M–Cl]+, 468 [M–2Cl] +, 
382 [M–CrCl3].  μeff = 3.89 BM. 
 
N,N-bis((1-Me-benzimidazol-2-yl)methyl)amine chromium(III) chloride [Cr(12)Cl3] 
 
A slurry of 0.50 g (1.64 mmol) N,N-bis(2-(1Me-benzimidazol-2-yl)methyl)amine 12 and 0.61 
g (1.64 mmol) [CrCl3(THF)3] in 20 ml THF was stirred at reflux for 4 hours. The obtained 
green solid was filtered, washed with THF (3x10 mL) and dried under reduced pressure. 
Yield 0.39 g (51.0%). Anal. Calc. for C18H19N5CrCl3,: C 46.62, H 4.13, N 15.10. Found C 
46.54, H 4.15, N 15.01. FT-IR, cm–1: 3246(s), 2857 (m), 1621 (m), 1541 (w), 1492 (m), 1474 
(v.s), 1465 (v.s), 1414 (m), 1382 (m), 1331 (m), 1272 (s), 1210 (w), 1147 (w), 1055 (s), 1003 
(s), 981 (s), 944 (w), 919 (m), 977 (s), 752 (v.s), 702 (s), 654 (m), 558 (w), 518 (w), 510 (w), 
431 (w), 418 (w).µeff = 3.91 BM. 
 
N,N-bis((1-Me-benzimidazol-2-yl)methyl)-N-(methyl)amine chromium(III) chloride 
[Cr(13)Cl3] 
A slurry of 0.50 g (1.56 mmol) N,N-bis(2-(1-Me-benzimidazol-2-yl)methyl)-N-
(methyl)amine 13 and 0.59 g (1.56 mmol) [CrCl3(THF)3] in 20 ml THF was stirred at reflux 
for 4 hours. The obtained green solid was filtered, washed with THF (3x10 mL) and dried 
under reduced pressure. Yield 0.64 g (85.8%). Anal. Calc. for C19H21N5CrCl3,: C 47.77, H 
4.43, N 14.66. Found, C 47.59, H 4.40, N 14.64.  FT-IR, cm–1: 3246 (v.s), 2857 (s), 1621 (m), 
1595 (m), 1541 (w), 1492 (m), 1475 (v.s), 1462 (v.s), 1382 (m), 1382 (s), 1332 (m), 1272 (s), 
1210 (w), 1146 (w), 1094 (w), 1055 (m), 1003 (s), 982 (s), 944 (w), 919 (m), 878 (s), 752 
(v.s), 702 (s), 654 (m), 558 (w), 518 (w), 510 (w), 431 (w), 417 (w).   µeff = 3.74 BM. 
 
O-bis((1H-benzimidazol-2-ylmethyl)-ether chromium (III) chloride [Cr(14)Cl3] 
 
Complex [Cr(14)Cl3] was synthesised by a procedure analogous to that described for 
[Cr(1)Cl3] using 14 (0.7 g, 2.5 mmol) and [CrCl3(THF)3] (0.94 g, 2.5 mmol) in 20 ml of 
THF. Yield 0.96 g, 85%.  Anal. Calc. for C16H14Cl3CrN4O (F.W. 436.7): C 44.01, H 3.23, N 
12.83 %. Found C 44.19, H 3.38, N 12.70 %.  IR (KBr, cm–1), 3232 (NH, s), 1620-1540 
(ArC=C, C=N, m), 1477-1454 (N-H, s), 1054-1043 (C-O, s), 749 (CH, s).  FAB(+) MS (m/z), 
400[M–Cl]+, 365[M–2Cl]+, 329 [M–3Cl]+.  μeff = 3.66 BM. 
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S-bis((1H-benzimidazol-2-yl)methyl)-thioether chromium(III) chloride [Cr(15)Cl3] 
 
Complex [Cr(15)Cl3] was synthesised by a procedure analogous to that described for 
[Cr(1)Cl3] using 15 (0.58 g, 1.96 mmol) and [CrCl3(THF)3] (0.73 g, 1.96 mmol). Yield 0.75 
g, 85%.  Anal. Calc. for C16H14Cl3CrN4S (F.W. 452.7): C 42.45, H 3.12, N 12.38 %. Found C 
42.59, H 3.22, N 12.27 %.  IR (KBr, cm–1), 3448 (Ar-H, s), 1622, 1593 (C=C, C=N, m), 
1486, 1467, 1452 (N-H, s), 1277 (C-N, s), 1046 (CS, s), 744(CH, s).  FAB(+) MS (m/z), 416 
[M–Cl]+, 381 [M–2Cl]+.  μeff = 3.89 BM. 
 
1,1-Bis(1H-benzimidazol-2-ylmethyl)-ethane chromium(III) chloride [Cr(16)Cl3] 
Complex [Cr(16)Cl3] was synthesised by a procedure analogous to that described for 
[Cr(1)Cl3] using 16 (0.6 g, 2.07mmol) and [CrCl3(THF)3] (0.78 g, 2.07 mmol). Yield 0.86 g, 
92 %.  Anal. Calc. for C18H18Cl3CrN4 (F.W. 448.7): C 48.18, H 4.04, N 12.49 %. Found C 
48.10, H 4.17, N 12.31 %.  IR (KBr, cm–1), υ 3384 (Ar-H, s), υ 1626-1560 (ArC=C, C=N, s), 
δ 1488, 1460 (N-H, s), υ 1222 (NC, s), δ 757 (CH, s).  FAB(+) MS (m/z), 412 [M–Cl]+, 377 
[M–2Cl]+.  μeff = 3.88 BM. 
 
N-bis((1H-benzimidazol-2-yl)ethyl)amine chromium chloride [Cr(18)Cl3] 
Ligand 18 (0.20 g, 0.49 mmols), chromium(III) chloride tetrahydrofuran complex (0.246 g, 
0.49 mmols) and 20 mL of dry THF were stirred and heated at 60 oC for 16 hours under a 
nitrogen atmosphere.  An insoluble solid formed which was filtered off, washed with 10 mL 
of dry THF and dried in vacuo. The product was obtained as a light brown amorphous solid; 
0.151 g (66 %); IR νmax/cm–1 (KBr) 3445 (m, N–H stretch), 3168, 2808 (s, aromatic and 
aliphatic C-H stretch), 1619, 1540 (m, C=N stretch), 1456, 1403 (s, aromatic C=C stretch and 
aliphatic C-H bending), 1260 (s, C-N stretch), 759 (s, aromatic C-H bending); MS (LSIMS): 
m/z 427 ([M–Cl]+, 15 %) & 392 ([M–2Cl]+, 10 %); Calc. for C18H19N5CrCl3: C, 46.60; H, 
4.13; N, 15.11. Found: C, 46.69; H, 3.91; N, 14.91 %; µeff = 3.5 BM. 
 
N-bis((1H-benzimidazol-2-yl)ethyl)-N-(methyl)amine chromium chloride [Cr(19)Cl3] 
Compound 19 (0.20 g, 0.60 mmols), chromium(III) chloride tetrahydrofuran complex (0.225 
g, 0.60 mmols) and 20 mL of dry DCM were stirred and heated at 35 oC  for 16 hours under a 
nitrogen atmosphere.  An insoluble solid formed which was filtered off, washed with 10 mL 
of dry THF and 10 mL of dry DCM and dried in vacuo.  The product was obtained as a lilac 
amorphous solid; 0.145 g (49 %); IR νmax/cm–1 (KBr) 3408 (m, N-H stretch), 3151, 2968 (s, 
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aromatic and aliphatic C–H stretch), 1618, 1560 (m, C=N stretch), 1485, 1458 (s, aromatic 
C=C stretch and aliphatic C-H bending), 1274 (s, C-N stretch), 746 (s, aromatic C-H 
bending); MS (LSIMS): m/z 455 ([M–Cl]+, 10 %) & 420 ([M–2Cl]+, 5 %); Calc. for 
C20H23N5CrCl3: C, 48.83; H, 4.72; N, 14.24. Found: C, 48.69; H, 4.61; N, 14.03 %; µeff = 4.2 
BM. 
 
Bis(1H-benzimidazol-2-yl)methane chromium(III) trichloride [Cr(20)Cl3] 
The ligand 20 (0.626g, 2.5 mmol) and [CrCl3(THF)3] (0.943 g, 2.5 mmol) were combined in 
30 ml THF under nitrogen.  The mixture was stirred for 3 days and the intensely dark green 
suspension was filtered, washed with thf and dried, to leave the product as a dark green 
powder (0.730 g, 78%).  IR νmax/cm–1 (KBr) 3126 (br, N-H stretch), 1624 (m, C=N stretch), 
1595 and 1537 (m, aromatic C=C stretch and aliphatic C-H bending), 1467 (s, NH, bend), 
1047 (m), 744 (s, aromatic C-H bending) 333 (s, N–Cr). MS (ESI): m/z 404 
([M+H+MeOH]+, 15 %).  Calc. for C15H12N4CrCl3: C, 44.30; H, 2.97; N, 13.78. Found: C, 
44.42; H, 3.16; N, 13.59 %. 
 
N-Bis((3,5-dimethylpyrazol-1-yl)methyl)-N-(butyl)amine chromium(III) chloride 
[Cr(21)Cl3] 
A solution of 0.50 g (1.73 mmol) N-bis((3,5-dimethylpyrazol-1-yl)methyl)-N-(butyl)amine 
(21) in 10 ml dry THF was added to a suspension of 0.65 g (1.73 mmol) [CrCl3(THF)3] in 10 
ml THF and the reaction mixture stirred at room temperature for 18 hours. Shortly after the 
start the colour of the reaction mixture changed from purple to green and at the end of the 
reaction green precipitate was formed. The solid was filtered off, washed with 5 ml 
tetrahydrofuran and 3x10 ml diethyl ether and dried at room temperature under reduced 
pressure for 5 hours. Yield – 0.72g (93.4%).  Anal. Calc. for (found): C 42.92 (42.83), H 6.08 
(6.17), N 15.64 (15.54).  FT-IR (cm–1): 574 (v.w), 600 (v.w), 628 (w), 695 (w), 796 (s), 845 
(m), 966 (w), 1031 (s), 1053 (v.s), 1119 (s), 1139 (w), 1258 (m), 1279 (s), 1300 (s), 1377 
(v.s), 1418 (v.s), 1422 (s), 1465 (v.s), 1492 (s), 1557 (v.s), 2873 (m), 2932 (s), 2961 (v.s), 
3127 (w). µeff = 3.98 BM 
 
N-bis((1H-benzimidazol-2-yl)methyl)-N-(methyl)amine chromium(0) tricarbonyl 
[Cr(2)(CO)3] 
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Freshly prepared [Cr(CO)3(NCMe)3] (0.08 g, 0.32 mmol), from [Cr(CO)6] (2.00 g, 9.10 
mmol) heated at reflux for 24 h in acetonitrile (60 mL), and 2 (0.09 g, 0.32 mmol) were 
stirred overnight in THF at room temperature.  The product was isolated by filtration, washed 
with Et2O (3 x 10 mL) and dried under vacuum. [Cr(2)(CO)3] was obtained as an orange air-
sensitive solid.  Recrystallisation from cold (–20 °C) THF solution gave crystals suitable for 
X-ray analysis.  Yield 0.12 g, 85%.  Anal. Calc. for C20H17CrN5O3 (F.W. 427.4): C 56.21, H 
4.01, N 16.39 %. Found C 56.17, H 4.15, N 16.42 %.  1H NMR (250 MHz, J = Hz, DMSO-
d6), δ 3.26 (s, 3H, NCH3), 4.19 (dd, 2JHaHb = 16.90, CHaHb), 7.16 (m, 4H, nJHH = 7.33, ArH), 
7.34 (d, 2H, JHH = 7.33, ArH), 8.02 (d, 2H, JHH = 7.93, ArH).  13C{1H} NMR (62.9 MHz, 
DMSO-d6) δ 25.1 (NCH3), 60.1 (NCH2Cq), 111.7 (ArC), 118 (ArC), 122.6 (ArC), 134.0 
(ArC), 141.8 (ArCipso), 153.9 (ArCq), 223.1 (C=O).  FAB(+) MS (m/z), 427 [M]+, 358 [M–
2(CO)–Me]+, 343 [M–3(CO)]+. 
 
Cationic complexes 
Trans-dichloro(mer-N-bis((1H-benzimidazol-2-yl)methyl)amine)(tetrahydrofuran) 
chromium(III) hexafluoroantimonate [Cr(1)Cl2(thf)]SbF6 
 
Silver hexafluoroantimonate (0.24 g, 0.69 mmol) and complex [Cr(1)Cl3] (0.3 g, 0.69 mmol) 
were stirred in THF (20 ml) at room temperature overnight. The solution was filtered, the 
solvent removed under reduced pressure, the product washed twice with diethyl ether (2 x 20 
ml) and dried under vacuum. Attempts to crystallise the complex from a THF solution 
resulted in blue crystals that were analysed as [Cr(1)Cl2(OH2)]SbF6, probably due to 
adventitious moisture in the system. Yield 0.375 g (77 %).  Anal. Calc. for 
C20H23Cl2CrF6N5OSb (F.W. 708.1): C 33.92, H 3.27, N 9.80 %. Found C 33.70, H 3.26, N 
9.60 %. IR (KBr, cm–1), 3202 (NH, m), 3164 (Ar-H), 1622-1544 (ArC=C, C=N, m), 1497, 
1477, 1456 (N-H, s), 1278 (CN, s), 748 (CH, s), 660 (Sb-F, s). UV-VIS (DMF), λmax/nm 
(εmax/dm3mol–1cm–1) = 440 (120), 647 (100), 726 (shoulder). FAB(+) MS (m/z), 401 [M–
THF]+, 364 [M–THF–Cl]+, 328 [M–THF–2Cl]+. FAB(–) MS (m/z), 235 [SbF6]–.  μeff = 4.10 
BM. 
 
Cis-dichloro(fac-N-bis(1H-benzimidazol-2-ylmethyl)-N-
(phenyl)amine)(tetrahydrofuran) chromium(III) hexafluoroantimonate 
[Cr(9)Cl2(thf)]SbF6 
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The procedure used was as described for [Cr(1)Cl2(thf)]SbF6, using ligand 9 (0.09 g, 0.18 
mmol) and silver hexafluoroantimonate (0.06 g, 0.18 mmol) to afford [Cr(9)Cl2(thf)]SbF6 as 
a green solid. Yield 0.10 g (72 %).  Anal. Calc. for C26H27Cl2Cr F6N5OSb (F.W. 784.2): C 
39.82, H 3.47, N 8.93 %. Found C 39.72, N 3.58, N 8.73 %.  IR (KBr, cm-1), 3390 (NH, s), 
3066 (Ar-H, s), 1623-1554 (ArC=C, N=C, m), 1498, 1479, 1454 (N-H, s), 1276 (CN, m), 
1053 (C-O, m), 751 (CH, s), 665 (Sb-F, vs).  UV-VIS (DMF), λmax/nm (εmax/dm3 mol–1 cm–1), 
441(118), 644(103), 725.  FAB(+) MS (m/z), 475 [M–(SbF6)–THF]+, 440 [M–(SbF6)–THF–
Cl]+.  FAB(–) MS (m/z), 235 [SbF6]–.  μeff = 4.12 BM. 
 
Bis(benzimidazol-2-ylmethyl)methylamine(dimethyl)aluminium trimer [(AlMe2)2(2')]3 
 
A solution of trimethylaluminium in heptane (2M, 1.7 ml, 3.4 mmol) was added to a 
suspension of 0.5 g (1.7 mmol) bis(benzimidazol-2-ylmethyl)methylamine (2) in 20 ml dry 
toluene, at –78 ˚C.  The reaction mixture was stirred at –78 ˚C for 10 minutes and the cooling 
bath removed.  While warming up to room temperature, the solid gradually dissolved forming 
a pale blue solution.  The reaction mixture was stirred additionally for 2 hours at room 
temperature and then approximately 3/4 of the solvent removed under reduced pressure.  The 
addition of 5 ml dry n-heptane resulted in the formation of off-white precipitate, which was 
filtered, washed with 5 ml cold n-heptane and dried under reduced pressure.  Crystals suitable 
for X-ray analysis were obtained from a toluene/heptane solution.  Yield - 0.55 g (80 %).  1H 
NMR (400 MHz, C6D6, 298K), ppm: 7.08 - 7.55 (28H, Ar-H), 2.18 - 3.92 (21H, CH2-N and 
CH3-N), -0.88 - 1.58 (36H, CH3-Al). 13C{1H} NMR (101 MHz, C6D6, 298K), ppm: 153.9, 
153.7, 153.5, 142.4, 142.0, 141.9, 139.4, 138.9, 138.8, 137.7, 129.3, 128.5, 125.6, 123.9, 
123.6, 123.4, 122.8, 122.2, 117.3, 117.1, 116.9, 116.2, 115.8, 115.4, 58.2, 57.2, 44.9, 43.8, 
21.7, –5.1, –5.7, –6.1, –6.5. 
 
General Polymerisation Procedure. Due to the insoluble nature of the chromium 
catalysts in the polymerisation solvent, toluene, the complexes were first pre-activated with 
the co-catalyst, methylaluminoxane (MAO).  This solution was diluted with toluene in order 
to give a solution with a suitable catalyst concentration.  The activated catalyst solution 
showed no significant loss of activity when stored at 5 ˚C for up to 2 weeks.  In practice, 
catalyst solutions were freshly prepared by combining the pre-catalyst with the co-catalyst at 
room temperature and the activated solutions were used within the same day.  A 
mechanically stirred pressure reaction vessel was filled with toluene (200 mL) followed by 
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addition of MAO as a moisture scavenger.  The pressure reaction vessel was submerged in a 
water bath set to the desired polymerisation temperature and the solvent saturated with 
ethylene at a pressure of 1 bar.  The polymerisation was initiated by injection of an aliquot of 
the activated catalyst solution. Immediately after the injection the ethylene pressure was 
adjusted to the required pressure and kept constant over the reaction time.  Reaction 
temperatures were measured inside the reactor.  For highly active catalysts, nano-molar 
concentrations of catalyst were used in order to limit the rise in reaction temperature to less 
than 3 ˚C.  After one hour the reaction was terminated by turning off the ethylene supply and 
venting off excess unreacted monomer.  A known amount of GC standard (nonane or 
2,2,4,4,6,8,8-heptamethylnonane) was added to the reaction mixture and then a small sample 
of the liquid phase was taken and passed through neutral alumina (Al2O3 micro column) to 
remove any catalyst, and then analysed by FID-GC.  The remaining polymer product was 
precipitated by the addition of methanol (200 mL), followed by dilute HCl (20 mL).   
 
Supporting Information 
NMR spectra, GC chromatograms, additional graphs, crystallographic details and information 
regarding DFT calculations. 
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